GeneCapture
GeneCapture is dedicated to revolutionizing infection detection through its innovative CAPTURE Platform™, which enables rapid pathogen identification and antimicrobial susceptibility testing at the point-of-care. The company aims to provide actionable answers quickly, addressing the growing challenges of antimicrobial resistance and the need for timely medical responses in various environments, including clinics, communities, and military settings.
What We Do
The CAPTURE Platform™
A portable technology solution for pathogen identification and antibiotic susceptibility testing that provides results in one hour for pathogen ID and another hour for antibiotic susceptibility. It supports multi-pathogen detection from various sample types without the need for lab equipment or refrigeration.
Application Area
Diagnostics
Key People
Krishnan Chittur, PhD
Co-Founder & CTO
Paula Millirons
Chief Scientist & PI
Greg Thompson
Chief Operating Officer
News & Updates
Significant Rise in Global Fungal Infections Affecting Civilian and Military Health
Significant Rise in Global Fungal Infections Affecting Civilian and Military Health
Awarded Matching SBIR Grant from Innovate Alabama to Enable Remote Infection Detection for Animal and Agricultural Applications
Prestigious Award Recognizes GeneCapture’s Advances in Breakthrough Rapid Pathogen Detection Platform
GeneCapture has won contracts from two Department of Defense agencies to prepare its portable rapid pathogen detection technology for independent and in-field testing, bringing total awards from the DOD to $5.5 Million.
Innovation Award
Recognized for innovative solutions in rapid pathogen detection.